• ASBMB 2016 Annual Meeting

Non-Alcoholic Fatty Liver Disease

Sponsored by the Minority Affairs Committee

Oral presentations selected from volunteered abstracts will also be programmed for a poster presentation. Programming notifications will be sent in January.  We look forward to seeing you at the 2016 ASBMB Annual Meeting, April 2 - 6, 2016, San Diego, Calif.
Theme Organizers: David D. Moore, Baylor College of Med

Sunday, April 3, 2016
San Diego Convention Center, Room 6F
9:45 am - 12:00 pm
Hepatic Lipid Signaling: NAFLD and Beyond 
Session Chair: TBD

Regulation of Liver Energy Balance by Nuclear Receptors
David D. MooreBaylor College of Med.
Hedgehog Signaling in NAFLD
Anna Mae DiehlDuke Univ. Med. Ctr.
JNK Signaling in Hepatic Disease

Roger J. DavisUniv. of Massachusetts Med. Sch./HHMI

Monday, April 4, 2016
San Diego Convention Center, Room 6F
4:00 pm - 6:15 pm
NAFLD: Genetic Determinants & Extrahepatic Complications

Session Chair: David D. Moore, Baylor College of Med.

Mitochondrial Protonophores for Treatment of NAFLD/NASH and Type 2 Diabetes
Gerald I. ShulmanYale Univ./HHMI
Genetic and Environmental Risk Factors for Progression of NASH
Rohit LoombaUniv. of California, San Diego
The Early Origins of NAFLD in Humans and Non-Human Primates

Jacob E. FriedmanUniv. Colorado, Denver

Tuesday, April 5, 2016
San Diego Convention Center, Room 6F
9:45 am - 12:00 pm
NAFLD: Metabolic Insight into the Enzymatic Players

Session Chair: TBD

Posttranscriptional Regulation of Lipogenesis
Jay D. HortonUT Southwestern Med. Ctr.
Acyl-CoA Thioesterases (ACOTs): Metabolic Control and Pathogenic Roles in NAFLD
David E. CohenHarvard Univ.
Interactions of Branched-Chain Amino Acids and Lipids in Metabolic Disease

Christopher Newgard, Duke Univ.